Microneedle technology for potential SARS-CoV-2 vaccine delivery
Description
INTRODUCTION: Microneedle fabrication was conceptualised in the 1970s as devices for painless transdermal drug delivery. The last two decades have seen considerable research and financial investment in this area with SARS-CoV-2 and other vaccines
